Accéder au contenu
Merck
Toutes les photos(3)

Documents

SAB4200637

Sigma-Aldrich

Monoclonal Anti-phospho-RNA polymerase II CTD (pSer2) antibody produced in rat

clone 3E7C7, purified from hybridoma cell culture

Synonyme(s) :

POLR2, POLRA, RPB1, RPBh1, RPO2, RPOL2, RpIILS, hRPB220, hsRPB1, polymerase (RNA) II (DNA directed) polypeptide A 220kDa (POLR2A)

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme


About This Item

Code UNSPSC :
12352203
Nomenclature NACRES :
NA.41

Source biologique

rat

Niveau de qualité

Forme d'anticorps

purified immunoglobulin

Type de produit anticorps

primary antibodies

Clone

3E7C7, monoclonal

Poids mol.

~250 kDa

Espèces réactives

rat, canine, mouse, human, monkey

Concentration

~1 mg/mL

Technique(s)

flow cytometry: 10 μg/test using using HeLa cells.
immunoblotting: 0.25-0.5 μg/mL using whole extracts of HeLa cells.
immunofluorescence: 4-8 μg/mL using using A549 cells

Isotype

IgG2a

Numéro d'accès UniProt

Conditions d'expédition

dry ice

Température de stockage

−20°C

Modification post-traductionnelle de la cible

phosphorylation (pSer2)

Informations sur le gène

human ... POLR2A(5430)

Description générale

Monoclonal Anti-phospho-RNA polymerase II CTD (pSer2 ) (rat IgG2a isotype) is derived from the hybridoma 3E7C7 produced by the fusion of mouse myeloma cells and lymph node cells from rat immunized with a synthetic peptide containing phospho-Ser2 of human RNA Polymerase II CTD repeat. RNA polymerase II subunit A (RNAPII), also known as POLR2A, is the largest subunit of RNA polymerase II. The POLR2A gene is mapped to human chromosome 17p13.1. This polymerase contains a carboxy-terminal domain (CTD) composed of heptapeptide repeats. These repeats contain serine and threonine residues that are phosphorylated in actively transcribing RNA polymerase.

Spécificité

Monoclonal Anti-RNA polymerase II CTD (pSer2) recognizes specifically phospho-Ser2 RNAPII but not phosphor-Ser5 or phosphor-Ser7.

Immunogène

synthetic peptide containing phospho-Ser2 of human RNA Polymerase II CTD repeat.

Application

Monoclonal Anti-phospho-RNA polymerase II CTD (pSer2) antibody produced in rat may be used in:
  • immunoblotting
  • immunofluorescence
  • flow cytometry

Actions biochimiques/physiologiques

RNA polymerase II subunit A (RNAPII) is responsible for synthesizing messenger RNA in eukaryotes. The carboxy-terminal domain (CTD) is essential for polymerase activity. The CTD mediates the coupling of transcription and processing of the nascent RNA. It also plays roles in transcription, elongation and termination. Also, this subunit, in combination with several other polymerase subunits, forms the DNA binding domain of the polymerase, a groove in which the DNA template is transcribed into RNA. CTD is being dynamically modified during the transcription cycle. The phosphorylation of serine is needed for RNA capping and splicing factors recruitment.

Forme physique

Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide.

Stockage et stabilité

For extended storage, freeze at -20 0C in working aliquots. Repeated freezing and thawing or storage in “frost-free” freezers is not recommended. If slight turbidity occurs upon prolonged storage, clarify the solution by centrifugation before use. Working dilution samples should be discarded if not usedwithin 12 hours.

Clause de non-responsabilité

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Outil de sélection de produits.

Code de la classe de stockage

10 - Combustible liquids

Classe de danger pour l'eau (WGK)

WGK 1

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable


Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Jing-Ping Hsin et al.
Genes & development, 26(19), 2119-2137 (2012-10-03)
The C-terminal domain (CTD) of the RNA polymerase II largest subunit consists of multiple heptad repeats (consensus Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7), varying in number from 26 in yeast to 52 in vertebrates. The CTD functions to help couple transcription and processing of the
Ballachanda N Devaiah et al.
Proceedings of the National Academy of Sciences of the United States of America, 109(18), 6927-6932 (2012-04-18)
The bromodomain protein, BRD4, has been identified recently as a therapeutic target in acute myeloid leukemia, multiple myeloma, Burkitt's lymphoma, NUT midline carcinoma, colon cancer, and inflammatory disease; its loss is a prognostic signature for metastatic breast cancer. BRD4 also
Jun Odawara et al.
BMC genomics, 12, 516-516 (2011-10-21)
Cellular function is regulated by the balance of stringently regulated amounts of mRNA. Previous reports revealed that RNA polymerase II (RNAPII), which transcribes mRNA, can be classified into the pausing state and the active transcription state according to the phosphorylation
Steven Hahn
Nature structural & molecular biology, 11(5), 394-403 (2004-04-29)
Advances in structure determination of the bacterial and eukaryotic transcription machinery have led to a marked increase in the understanding of the mechanism of transcription. Models for the specific assembly of the RNA polymerase II transcription machinery at a promoter
HDP101, a novel B-cell maturation antigen (BCMA)-targeted antibody conjugated to alpha-Amanitin, is active against myeloma with preferential efficacy against pre-clinical models of deletion 17p
Singh R K, et al.
Blood, 132(Supplement 1), 593-593 (2018)

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique